DZNE scientists have discovered a molecular mechanism that may help in the search for effective treatments of progressive supranuclear palsy (PSP). Their study focusses on a protein called PERK.

Epigenetics may open new therapeutic avenues. DZNE scientists report on this in the journal PNAS.

The diet influences epigenetic patterns in the genome. DZNE Researchers report on this in journal “Molecular Psychiatry”.

Hewlett Packard Enterprise Cooperates with the DZNE – Employs Memory-Driven Computing in Brain Research

Today, Federal Chancellor Angela Merkel and NRW Science Minister Svenja Schulze inaugurated the new building of the DZNE in Bonn and took the opportunity to learn about current research projects.

Scientists from BfArM and the DZNE will be working together and in cooperation with the statutory health insurance company Techniker Krankenkasse to investigate the influence of pharmacogenetic factors on the effectiveness and safety of drug therapies. …

In a laboratory study, DZNE researchers have found that "alpha-synuclein", a protein involved in Parkinson's disease, is capable of travelling from the brain to the stomach using the vagus nerve as a conduit.